Advancing Liver Cancer Care: Highlights from the BCLC 2024 Meeting On November 25th and 26th, DiCE virtually attended the Barcelone Clinic Liver Cancer (BCLC) annual conference, which was titled “Forging a M […]

Empowering Cancer Patients: SmartCARE Showcase Event The SmartCARE Showcase Event, organised by the European Cancer Organisation, brought together patient advocates, clinicians, and IT experts to […]

Reflecting on ENTERO 2024 – A Milestone for Early-Age Onset Digestive Cancers On November 14 and 15, Digestive Cancers Europe (DiCE) and EuropaColon Portugal proudly hosted ENTERO 2024 in the scenic city of Porto, […]

Advancing Rare Cancer Care: DiCE at the EURACAN Board Meeting On the 7th and the 8th of November, Laura Urena from Digestive Cancers Europe (DiCE) and a member of EURACAN Patient Advocacy Group (EPAG), […]

United Against Cancer: Driving Policy and Advocacy at the European Cancer Summit 2024 Belgium-based part of the DiCE team was happy to be able to attend the European Cancer Summit 2024, hosted by the European Cancer Organisation […]

Wolfram Nolte Memorial Award 2024: Celebrating Innovation in Colorectal Cancer Care The Wolfram Nolte Memorial Award is presented annually to projects that address the unmet needs of patients and carers affected by colorectal cancer […]

Tevimbra (tislelizumab) Receives New European Recommendations for Oesophageal and Gastric Cancer On October 17, 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) endorsed two new therapeutic indications f […]

Ponsegromab: A New Hope for Cancer Cachexia Treatment Cancer cachexia, a severe wasting syndrome often experienced by patients with advanced cancer, leads to substantial weight loss, muscle wasting, and […]

Empowering Patient Voices at the National Congress of Medical Oncology I am thrilled to share my experience of being invited to speak at the National Congress of Medical Oncology opening ceremony. This prestigious event […]

Zorana Maravic, DiCE CEO, Co-Chairs Global Effort for Medicine Accessibility In an inspiring move toward global healthcare improvement, Zorana Maravic, CEO of Digestive Cancers Europe (DiCE), took centre stage as co-chair of […]

New Era in Gastric Cancer Treatment: Zolbetuximab Gains EU Approval On 20 September 2024, the European Commission approved zolbetuximab in combination with chemotherapy to treat advanced and metastatic Gastric and […]

Hepatocellular Carcinoma Prevention & Diagnosis: DiCE Publishes Project Results Hepatocellular carcinoma (HCC, the most common form of liver cancer) is an often preventable disease with several treatment options available to […]

DiCE Proud to Be Part of #UEGWeek2024 Collaboration and partnerships are fundamental to our work, so it was a pleasure to participate in UEG Week again this year, held in Vienna. It […]

Help Shape the Future of Gastric Cancer Screening in Europe The TOGAS consortium invites you to participate in a survey on gastric cancer screening. TOGAS is an EU co-funded project exploring the […]

The POLAR Promise: Groundbreaking Survival Gains for Targeted Pancreatic Cancer Patients in Phase II Trial Phase II trial of Pembrolizumab Immunotherapy and Olaparib (POLAR) trial: new data presented at the European Society for Medical Oncology (ESMO) 2024 […]

DiCE at ESMO 2024 Earlier this month, part of the DiCE Medical and Scientific Team attended the ESMO (European Society for Medical Oncology) Congress 2024 in […]

DiCE Attends the TOGAS EU Project Consortium Meeting and Conference Zorana Maravic, our CEO, and Ana Martins, DiCE medical and scientific project manager, participated in the TOGAS Consortium Meeting and TOGAS […]

DiCE Attends The Horizon Europe Cancer Mission ‘Diagnosis and Treatment’ Cluster Meeting On September 12th in sunny Barcelona, DiCE, a member of the SAGITTARIUS EU Project, participated in the Horizon Europe Cancer Mission’s ‘ […]